Results 191 to 200 of about 65,328 (289)
Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment. [PDF]
Grand TS +10 more
europepmc +1 more source
ABSTRACT This study presents a multi‐method non‐invasive investigation of an approximately 4‐ha area associated with the long‐occupied coastal settlement of Rocavecchia (Apulia, southern Italy), situated between the prehistoric fortified peninsula and the Hellenistic‐Messapian walls.
Giuseppe Guarino +3 more
wiley +1 more source
An improved agricultural household margin insurance scheme with insured-insurer risk protection: a time-varying copula approach. [PDF]
Ahdika A +3 more
europepmc +1 more source
Objective Regular imaging by conventional radiography to assess for joint damage is a cornerstone in the management of rheumatoid arthritis. Scoring systems to quantify such damage, such as the widely used Sharp/van der Heijde (SvdH) score, are limited by the requirement of time and experienced staff as well as intra‐ and interrater variability.
Thomas Deimel +6 more
wiley +1 more source
Driving Into the Unknown: ASM Reductions After Intracranial EEG. [PDF]
Lapalme-Remis S.
europepmc +1 more source
“Dead Lithium” Formation and Mitigation Strategies in Anode‐Free Li‐Metal Batteries
Anode‐free lithium metal batteries, though promising due to their high energy density, face challenges from dead lithium formation. “Dead lithium”, disconnected from the anode, causes capacity loss, increased resistance, and safety risks. This review explores the origins of dead lithium, its impact on battery performance, and potential strategies for ...
Mozaffar Abdollahifar, Andrea Paolella
wiley +1 more source
Reframing involuntary treatment as a sentinel event: a model for improving rights-based mental health care. [PDF]
Cossu G +4 more
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Engineering and Applying Quantum Contextuality. [PDF]
Pavičić M.
europepmc +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source

